SBH Sciences has extensive expertise in the analysis of large molecules, mainly cytokines, enzymes, and antibodies. Our bioanalytical services have assisted in the development of biotherapeutics based on peptides, recombinant proteins, monoclonal antibodies, T-cell engagers, virus-like particles (VLP), adeno-associated viruses (AAV), and complex carbohydrates.
The bioanalytical services offered by SBH Sciences cover the development of analytical methods and the analysis of biomarkers and biologic drugs using 12-platform technology. We advance the most complex therapeutical programs, from methodology development during discovery and preclinical phases to the analysis of clinical samples under GLP. In addition, we assist in drafting standard operating procedures (SOPs) and technology transfers to GMP partners to expedite critical deadlines.
We routinely develop quantitative bioanalytical methods to measure protein concentrations in biological fluids, including plasma, serum, cerebrospinal fluid (CSF) and urine, and in tissues from multiple species (including human, mouse, rat, pig, and non-human primates). We also work extensively with cell culture models, including primary cells and blood components. SBH Sciences has over 500 cell lines that can be customized for use in any in-vitro experiment or scaled up for in-vivo work.
We are dedicated to performing accurate, reliable, and streamlined bioanalytical services for the most challenging programs to help you make confident research decisions.
Our platform technologies include:
- Method development, qualification, and validation
- In-vitro studies to demonstrate proof-of-concept
- Analysis of samples to support preclinical studies
- Analysis of samples from human subjects to support clinical studies
- Biomarker analysis
Multiplex Services
Custom Development and Testing Services of MultiAnalyte Profiling (MAP)
SBH Sciences is pleased to offer Multiplex Cytokines Custom Development and Testing Services based on our Cytokine expertise and the Luminex® xMAP Technology. xMAP technology allows simultaneous quantification of MAP, including cytokines / chemokines / biomarkers in cell culture and biological samples.
Testing services - We offer MAP testing services based on already available commercial assays, for many applications including: Cancer Markers, Cardiac Markers, Growth Factors, and Transcription Factors.
Multiplexed bioassays - We provide cell-based bioassays in combination with MAP. Drug efficacy and dosage can be determined based on profiles of up to 50 analytes, utilizing our bioassay expertise and more than 200 in-house cell lines (Figure 3).
Custom bead development - No kit available for your biomarker? We can conjugate your antibodies of choice to build custom MAP kits. We also have experience in bead-peptide conjugation to screen for autoantibodies or protein binding partners. We will develop the assay, including standards, and evaluate, verify and optimize the dynamic range, signal linearity, assay specificity and will ensure Multiplex compatibility.
Our custom assays can be tailor-made for many applications including: Cancer Markers, Cardiac Markers, Growth Factors and Transcription Factors. It might assist to assess the mechanism of action for monoclonal antibodies, recombinant proteins, small molecule therapeutics across a range of disease states including cardiovascular, inflammation, immunology, oncology, and CNS disorders.
Biomarker production - Our expertise in the production and purification will be applied as well. SBH Sciences can assist you in the isolation of specific biomarkers from natural sources or production as recombinant proteins, while simultaneously developing your specific MultiAnalyte Method.
Please contact us so we can discuss your specific needs, and ways in which SBH Sciences might be able to work with you. We will be happy to assist you.
Our expertise is your competitive edge!